The -491A/T polymorphism of the apolipoprotein E gene is associated with the ApoEε4 allele and Alzheimer's disease

Neuroscience Letters

Volumn 263, Issue 2-3, 1999, Pages 217-219

  Ahmed, Abdel R H ^a   MacGowan, Sian H ^b   Culpan, Doris ^b   Jones, Roy W ^a   Wilcock, Gordon K ^b  

^a St Martin's Hospital   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

491 A i; ApoE4; Disease; Gender; Polymorphism

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CASE CONTROL STUDY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SENILE PLAQUE;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; FEMALE; GENOTYPE; HUMANS; MALE; POINT MUTATION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; VARIATION (GENETICS);

EID: 0033605707     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00126-3     Document Type: Article

References (9)

1. Artiga M.J., Bullido M.J., Sastre I., Recuero M., Garcia M.A., Aldudo J., Vazquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of Apolipoprotein E gene. FEBS Letts. 421:1998;105-108.
2. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
3. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of ApoE Type 4 allele and the risk of AD in late-onset families. Science. 261:1993;921-923.
4. Combarros O., Leno C., Oterino A., Berciano J., Fernandez-Luna J.L., Fernandez-Viadero C., Pena N., Miro J., Delgado M. Gender effect on Apolipoprotein E epsilon 4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol. Scand. 97:1998;68-71.
5. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 48(1):1997;132-138.
6. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Vanbelle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease. Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
7. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of Apolipoprotein E genotype in late-onset Alzheimer's Disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
8. Song Y.-Q., Rogaeva E., Premkumar S., Brindle N., Kawari T., Orlacchio An., Yu G., Levesque G., Nishimura M., Ikeda M., Pei Y., O'Toole C., Duara R., Barker W., Sorbi S., Freedman M., Farrer L., St. George-Hyslop P. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of ApoE. Neurosci. Lett. 250(3):1998;189-192.
9. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.